Skip to content

Wednesday, December 18, 2024

Latest:

Mapping functional relations among proteins and genes helps illuminate their role in cancer
Occupational therapy: what patients need to know
Holly jolly health tips for Santa (and you)
Championing better care for adolescents with iron deficiency: Highlighting the impact of quality improvement initiatives
SPACe: A new open-source platform that supports large imaging data analysis on standard computers

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

grade3-medulloblastoma

A potential new therapeutic target for Group 3 medulloblastoma

August 8, 2024 CAR T cell, grade3-medulloblastoma, Immunotherapy, pediatric brain cancer, protogenin, Research

Researchers identified and located a population of stem-like cells that initiates and maintains Group 3 medulloblastoma in the developing brain.

From the Labs: Image of the Month

From the Labs: Humans are complex genetic mosaics.

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951